Literature DB >> 32458296

On the Calculation of TCID50 for Quantitation of Virus Infectivity.

Chengfeng Lei1, Jian Yang1,2, Jia Hu1, Xiulian Sun3.   

Abstract

Year:  2020        PMID： 32458296      PMCID： PMC7973348          DOI： 10.1007/s12250-020-00230-5

Source DB:  PubMed          Journal:  Virol Sin        ISSN： 1995-820X            Impact factor:   4.327


× No keyword cloud information.
  3 in total

1.  TCID50 determination by an immuno dot blot assay as exemplified in a study of storage conditions of infectious pancreatic necrosis virus.

Authors:  L Svensson; A Hjalmarsson; E Everitt
Journal:  J Virol Methods       Date:  1999-06       Impact factor: 2.014

2.  Improvements in methods for calculating virus titer estimates from TCID50 and plaque assays.

Authors:  D D LaBarre; R J Lowy
Journal:  J Virol Methods       Date:  2001-08       Impact factor: 2.014

3.  Comparing lethal dose ratios using probit regression with arbitrary slopes.

Authors:  Chengfeng Lei; Xiulian Sun
Journal:  BMC Pharmacol Toxicol       Date:  2018-10-05       Impact factor: 2.483
  3 in total
  28 in total

1.  Quantification of Infectious SARS-CoV-2 by the 50% Tissue Culture Infectious Dose Endpoint Dilution Assay.

Authors:  C Korin Bullen; Stephanie L Davis; Monika M Looney
Journal:  Methods Mol Biol       Date:  2022

2.  Generation of a live attenuated influenza A vaccine by proteolysis targeting.

Authors:  Longlong Si; Quan Shen; Jing Li; Li Chen; Jinying Shen; Xue Xiao; Haiqing Bai; Tang Feng; Adam Yongxin Ye; Le Li; Chunhe Zhang; Zhen Li; Ping Wang; Crystal Yuri Oh; Atiq Nurani; Siwen Niu; Chengxin Zhang; Xiaoqiong Wei; Wanqiong Yuan; Hao Liao; Xiaojie Huang; Ning Wang; Wen-Xia Tian; Hongwei Tian; Li Li; Xiaoheng Liu; Roberto Plebani
Journal:  Nat Biotechnol       Date:  2022-07-04       Impact factor: 68.164

3.  The gC1qR Binding Site Mutant PCV2 Is a Potential Vaccine Strain That Does Not Impair Memory CD4+ T-Cell Generation by Vaccines.

Authors:  Qian Du; Xuefeng Yang; Mengyu Ma; Qi Zhang; Changlei Zhu; Tengfei Shi; Mingrui He; Dewen Tong; Yong Huang
Journal:  J Virol       Date:  2022-09-19       Impact factor: 6.549

4.  Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection.

Authors:  Kylie M Konrath; Kevin Liaw; Yuanhan Wu; Xizhou Zhu; Susanne N Walker; Ziyang Xu; Katherine Schultheis; Neethu Chokkalingam; Himanshi Chawla; Jianqiu Du; Nicholas J Tursi; Alan Moore; Jared Adolf-Bryfogle; Mansi Purwar; Emma L Reuschel; Drew Frase; Matthew Sullivan; Benjamin Fry; Igor Maricic; Viviane M Andrade; Christel Iffland; Max Crispin; Kate E Broderick; Laurent M P F Humeau; Ami Patel; Trevor R F Smith; Jesper Pallesen; David B Weiner; Daniel W Kulp
Journal:  Cell Rep       Date:  2022-01-11       Impact factor: 9.995

5.  Correlating qRT-PCR, dPCR and Viral Titration for the Identification and Quantification of SARS-CoV-2: A New Approach for Infection Management.

Authors:  Martina Brandolini; Francesca Taddei; Maria Michela Marino; Laura Grumiro; Agata Scalcione; Maria Elena Turba; Fabio Gentilini; Michela Fantini; Silvia Zannoli; Giorgio Dirani; Vittorio Sambri
Journal:  Viruses       Date:  2021-05-28       Impact factor: 5.048

6.  Effect of Ethanolic Caesalpinia sappan Fraction on In Vitro Antiviral Activity against Porcine Reproductive and Respiratory Syndrome Virus.

Authors:  Chaiwat Arjin; Surat Hongsibsong; Kidsadagon Pringproa; Mintra Seel-Audom; Warintorn Ruksiriwanich; Kunrunya Sutan; Sarana Rose Sommano; Korawan Sringarm
Journal:  Vet Sci       Date:  2021-06-09

7.  SARS-CoV-2 targets neurons of 3D human brain organoids.

Authors:  Anand Ramani; Lisa Müller; Philipp N Ostermann; Elke Gabriel; Pranty Abida-Islam; Andreas Müller-Schiffmann; Aruljothi Mariappan; Olivier Goureau; Henning Gruell; Andreas Walker; Marcel Andrée; Sandra Hauka; Torsten Houwaart; Alexander Dilthey; Kai Wohlgemuth; Heymut Omran; Florian Klein; Dagmar Wieczorek; Ortwin Adams; Jörg Timm; Carsten Korth; Heiner Schaal; Jay Gopalakrishnan
Journal:  EMBO J       Date:  2020-09-23       Impact factor: 11.598

8.  Designing and Testing of a System for Aerosolization and Recovery of Viable Porcine Reproductive and Respiratory Syndrome Virus (PRRSV): Theoretical and Engineering Considerations.

Authors:  Peiyang Li; Jacek A Koziel; Jeffrey J Zimmerman; Steven J Hoff; Jianqiang Zhang; Ting-Yu Cheng; Wannarat Yim-Im; Myeongseong Lee; Baitong Chen; William S Jenks
Journal:  Front Bioeng Biotechnol       Date:  2021-05-10

9.  Antiviral Activity of Ribavirin against Tilapia tilapinevirus in Fish Cells.

Authors:  Tuchakorn Lertwanakarn; Pirada Trongwongsa; Sangchai Yingsakmongkol; Matepiya Khemthong; Puntanat Tattiyapong; Win Surachetpong
Journal:  Pathogens       Date:  2021-12-10

10.  FMDV Leader Protein Interacts with the NACHT and LRR Domains of NLRP3 to Promote IL-1β Production.

Authors:  Sk Mohiuddin Choudhury; Xusheng Ma; Yuanyuan Li; Xiaofeng Nian; Zhikuan Luo; Yonghua Ma; Zixiang Zhu; Fan Yang; Weijun Cao; Haixue Zheng
Journal:  Viruses       Date:  2021-12-23       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.